ghk-cu + bpc blend
GHK-Cu plus BPC-157 combines a copper peptide with an experimental repair peptide. Topical skin research and BPC-157 animal findings do not establish that injecting them together improves skin or connective tissue.
Copper peptide + BPC-157
- Copper peptide + BPC-157
- Topical evidence does not establish injectable blend outcomes
Is this a skin product or an injectable repair blend?
GHK-Cu evidence depends on its vehicle and route. Adding BPC-157 creates a different intervention, and topical-product results do not apply to an injected blend.
GHK-Cu · topical post-laser study
Human topical study
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin, 2006. PMID 16847171.
Topical GHK-Cu products did not significantly improve post-laser redness in this study. It neither tested an injected GHK-Cu blend nor established a general skin-repair benefit.
Read the original sourceFDA · BPC-157 evidence review
Regulatory safety assessment
FDA · BPC-157 evidence review
The FDA review separates laboratory and animal findings, limited human reports and marketed combination products. A product being sold or discussed in an advisory meeting does not establish a demonstrated benefit, a safe formulation or FDA approval.
Read the original sourceHas this exact combination been tested?
The cited records contain no controlled human outcome study of the specified GHK-Cu/BPC-157 finished combination. Reviews that discuss both ingredients do not show that they were administered together.
Exact combination · no controlled human study
Literature record set
PubMed and cited primary records.
The cited records contain no controlled human outcome study of the specified GHK-Cu/BPC-157 finished combination. Reviews that discuss both ingredients do not show that they were administered together.
Does the skin evidence show that this blend works?
The cited post-laser topical GHK-Cu study found no significant improvement in redness. It did not include BPC-157 or test an injected mixture.
GHK-Cu · topical post-laser study
Human topical study
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin, 2006. PMID 16847171.
Topical GHK-Cu products did not significantly improve post-laser redness in this study. It neither tested an injected GHK-Cu blend nor established a general skin-repair benefit.
Read the original sourceDoes GHK-Cu handle the surface while BPC-157 repairs deeper tissue?
No study shows that this blend targets skin and tendon separately. The exact combination needs its own exposure and outcome data before either effect can be claimed.
FDA · BPC-157 evidence review
Regulatory safety assessment
FDA · BPC-157 evidence review
The FDA review separates laboratory and animal findings, limited human reports and marketed combination products. A product being sold or discussed in an advisory meeting does not establish a demonstrated benefit, a safe formulation or FDA approval.
Read the original sourceExact combination · no controlled human study
Literature record set
PubMed and cited primary records.
The cited records contain no controlled human outcome study of the specified GHK-Cu/BPC-157 finished combination. Reviews that discuss both ingredients do not show that they were administered together.
What do we know about side effects?
Human safety data for injectable GHK-Cu and BPC-157 are limited, and FDA identifies immune-reaction and impurity concerns. No study provides a safety profile or injection-reaction rate for the combination.
Does a familiar cosmetic ingredient make injection safer?
Topical cosmetic use does not establish the exposure, excipients, sterility, product quality, or safety of an injected preparation.
FDA · ingredient safety concerns
Regulatory safety assessment
FDA · ingredient safety concerns
FDA describes limited human safety information for BPC-157 and concerns about impurities, product characterization and immune reactions. For injectable GHK-Cu, it identifies limited human safety data and possible aggregation or peptide impurities.
Read the original sourceCan the two peptides stay stable in the same vial?
That needs testing of the actual mixture. Separate ingredient certificates do not establish what happens after mixing, dilution or storage. The cited sources do not establish stability for a specified finished blend.
| Question | What testing must show |
|---|---|
| Identity | Which molecular forms are present. |
| Amount | How much of each component was measured. |
| Stability | What remains intact under the stated storage conditions. |
| Clinical effect | Whether the exact preparation improves the outcome claimed. |
Exact combination · no controlled human study
Literature record set
PubMed and cited primary records.
The cited records contain no controlled human outcome study of the specified GHK-Cu/BPC-157 finished combination. Reviews that discuss both ingredients do not show that they were administered together.
Studies and sources
GHK-Cu · topical post-laser study
Human topical study
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin, 2006. PMID 16847171.
Topical GHK-Cu products did not significantly improve post-laser redness in this study. It neither tested an injected GHK-Cu blend nor established a general skin-repair benefit.
Read the original sourceFDA · BPC-157 evidence review
Regulatory safety assessment
FDA · BPC-157 evidence review
The FDA review separates laboratory and animal findings, limited human reports and marketed combination products. A product being sold or discussed in an advisory meeting does not establish a demonstrated benefit, a safe formulation or FDA approval.
Read the original sourceFDA · ingredient safety concerns
Regulatory safety assessment
FDA · ingredient safety concerns
FDA describes limited human safety information for BPC-157 and concerns about impurities, product characterization and immune reactions. For injectable GHK-Cu, it identifies limited human safety data and possible aggregation or peptide impurities.
Read the original sourceExact combination · no controlled human study
Literature record set
PubMed and cited primary records.
The cited records contain no controlled human outcome study of the specified GHK-Cu/BPC-157 finished combination. Reviews that discuss both ingredients do not show that they were administered together.
Why is ghk-cu + bpc blend in A tier?
The A grade rests on separate evidence for GHK-Cu and BPC-157. No controlled human trial has tested the combination, and topical GHK-Cu findings do not establish the benefit of an injected blend.